179 related articles for article (PubMed ID: 12771997)
1. Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics.
Galmarini CM; Kamath K; Vanier-Viornery A; Hervieu V; Peiller E; Falette N; Puisieux A; Ann Jordan M; Dumontet C
Br J Cancer; 2003 Jun; 88(11):1793-9. PubMed ID: 12771997
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity.
Galmarini CM; Falette N; Tabone E; Levrat C; Britten R; Voorzanger-Rousselot N; Roesch-Gateau O; Vanier-Viornery A; Puisieux A; Dumontet C
Br J Cancer; 2001 Sep; 85(6):902-8. PubMed ID: 11556844
[TBL] [Abstract][Full Text] [Related]
3. Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine.
Rathinasamy K; Jindal B; Asthana J; Singh P; Balaji PV; Panda D
BMC Cancer; 2010 May; 10():213. PubMed ID: 20482847
[TBL] [Abstract][Full Text] [Related]
4. Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells.
Kavallaris M; Tait AS; Walsh BJ; He L; Horwitz SB; Norris MD; Haber M
Cancer Res; 2001 Aug; 61(15):5803-9. PubMed ID: 11479219
[TBL] [Abstract][Full Text] [Related]
5. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
[TBL] [Abstract][Full Text] [Related]
6. DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4.
Zhang CC; Yang JM; Bash-Babula J; White E; Murphy M; Levine AJ; Hait WN
Cancer Res; 1999 Aug; 59(15):3663-70. PubMed ID: 10446979
[TBL] [Abstract][Full Text] [Related]
7. βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel.
Smiyun G; Azarenko O; Miller H; Rifkind A; LaPointe NE; Wilson L; Jordan MA
Cancer Chemother Pharmacol; 2017 Jul; 80(1):151-164. PubMed ID: 28567478
[TBL] [Abstract][Full Text] [Related]
8. Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine.
Galmarini CM; Clarke ML; Falette N; Puisieux A; Mackey JR; Dumontet C
Int J Cancer; 2002 Feb; 97(4):439-45. PubMed ID: 11802204
[TBL] [Abstract][Full Text] [Related]
9. Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line.
Chang E; Donahue J; Smith A; Hornick J; Rao JN; Wang JY; Battafarano RJ
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):225-32. PubMed ID: 20236666
[TBL] [Abstract][Full Text] [Related]
10. Mutations in beta-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines.
He L; Yang CP; Horwitz SB
Mol Cancer Ther; 2001 Nov; 1(1):3-10. PubMed ID: 12467233
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.
Wang RC; Chen X; Parissenti AM; Joy AA; Tuszynski J; Brindley DN; Wang Z
PLoS One; 2017; 12(8):e0182400. PubMed ID: 28787019
[TBL] [Abstract][Full Text] [Related]
12. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
[TBL] [Abstract][Full Text] [Related]
13. An antitubulin agent BCFMT inhibits proliferation of cancer cells and induces cell death by inhibiting microtubule dynamics.
Rai A; Surolia A; Panda D
PLoS One; 2012; 7(8):e44311. PubMed ID: 22952952
[TBL] [Abstract][Full Text] [Related]
14. Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers.
Cheung CH; Chen HH; Kuo CC; Chang CY; Coumar MS; Hsieh HP; Chang JY
Mol Cancer; 2009 Jul; 8():43. PubMed ID: 19575780
[TBL] [Abstract][Full Text] [Related]
15. Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells.
Wang H; Vo T; Hajar A; Li S; Chen X; Parissenti AM; Brindley DN; Wang Z
BMC Cancer; 2014 Jan; 14():37. PubMed ID: 24447372
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.
Hoffman WH; Biade S; Zilfou JT; Chen J; Murphy M
J Biol Chem; 2002 Feb; 277(5):3247-57. PubMed ID: 11714700
[TBL] [Abstract][Full Text] [Related]
17. Neuronal-associated microtubule proteins class III beta-tubulin and MAP2c in neuroblastoma: role in resistance to microtubule-targeted drugs.
Don S; Verrills NM; Liaw TY; Liu ML; Norris MD; Haber M; Kavallaris M
Mol Cancer Ther; 2004 Sep; 3(9):1137-46. PubMed ID: 15367708
[TBL] [Abstract][Full Text] [Related]
18. Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells.
Hage-Sleiman R; Herveau S; Matera EL; Laurier JF; Dumontet C
BMC Cancer; 2010 Apr; 10():135. PubMed ID: 20384997
[TBL] [Abstract][Full Text] [Related]
19. ADP ribosylation factor like 2 (Arl2) protein influences microtubule dynamics in breast cancer cells.
Beghin A; Honore S; Messana C; Matera EL; Aim J; Burlinchon S; Braguer D; Dumontet C
Exp Cell Res; 2007 Feb; 313(3):473-85. PubMed ID: 17188265
[TBL] [Abstract][Full Text] [Related]
20. Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cells.
Lilling G; Nordenberg J; Rotter V; Goldfinger N; Peller S; Sidi Y
Cancer Invest; 2002; 20(4):509-17. PubMed ID: 12094546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]